Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimation of the number of people with Down syndrome in Latin America and the Caribbean.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Evaluating the rumen microbial community of genetically divergent spring-calving dairy cows grazing grass-only or grass-clover swards at different stages of the grazing season.

Frontiers in microbiology·2025
Same author

Characterisation of the bacterial and archaeal microbiota in fresh colostrum collected from a single, spring-calving dairy herd.

PloS one·2025
Same author

Temporal establishment of the colon microbiota in Angus calves from birth to post-weaning.

PloS one·2025
Same author

Countrywide Variables Associated With the Reduction of Fetuses With Down Syndrome.

American journal of medical genetics. Part A·2025
Same author

Estimation of the number of people with Down syndrome living in Canada.

Genetics in medicine : official journal of the American College of Medical Genetics·2025

Related Experiment Video

Updated: Jul 13, 2026

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
07:07

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze

Published on: October 29, 2019

Drug treatment improves memory in mice.

Frank Buckley1, Ben Sacks

  • 1The Down Syndrome Educational Trust, Portsmouth, Hampshire, UK. frank.buckley@downsed.org

Down'S Syndrome, Research and Practice : the Journal of the Sarah Duffen Centre
|August 19, 2007
PubMed
Summary

Mice with extra chromosome 21 genes showed improved memory after brain drug treatment. This research offers potential new avenues for pharmacological therapies for individuals with Down syndrome.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Down syndrome is associated with cognitive impairments, particularly in memory.
  • Mouse models with trisomy of chromosome 21 genes are used to study Down syndrome.
  • Pharmacological interventions are being explored to improve cognitive function in Down syndrome.

Purpose of the Study:

  • To investigate the effects of drugs targeting brain function on memory performance in mice with extra copies of genes similar to human chromosome 21.
  • To assess the potential of these pharmacological therapies for Down syndrome.

Main Methods:

  • Utilized a mouse model carrying additional copies of genes homologous to human chromosome 21.
  • Administered drugs designed to modulate brain function.

More Related Videos

The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents
09:01

The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents

Published on: July 8, 2015

Assessing Spatial Memory Impairment in a Mouse Model of Traumatic Brain Injury Using a Radial Water Tread Maze
06:09

Assessing Spatial Memory Impairment in a Mouse Model of Traumatic Brain Injury Using a Radial Water Tread Maze

Published on: July 17, 2017

Related Experiment Videos

Last Updated: Jul 13, 2026

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
07:07

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze

Published on: October 29, 2019

The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents
09:01

The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents

Published on: July 8, 2015

Assessing Spatial Memory Impairment in a Mouse Model of Traumatic Brain Injury Using a Radial Water Tread Maze
06:09

Assessing Spatial Memory Impairment in a Mouse Model of Traumatic Brain Injury Using a Radial Water Tread Maze

Published on: July 17, 2017

  • Assessed memory performance using standardized memory tests.

    • Main Results:

    • Mice with trisomy of chromosome 21 genes demonstrated enhanced performance on memory tests following drug treatment.
    • The specific drugs used targeted key pathways involved in brain function and memory.

    Conclusions:

    • Pharmacological targeting of brain function can improve memory in a mouse model of Down syndrome.
    • These findings suggest a potential breakthrough for developing new drug therapies to aid individuals with Down syndrome.